Eukedos S.p.A. (IT:EUK)
:EUK
Want to see IT:EUK full AI Analyst Report?
EUK Stock Chart & Stats
€0.72
-€0.02(-2.41%)
At close: 4:00 PM EST
€0.72
-€0.02(-2.41%)
Day’s Range― - ―
52-Week Range€0.45 - €0.82
Previous CloseN/A
Volume1.70K
Average Volume (3M)4.68K
Market Cap
€14.90M
Enterprise Value€143.22M
Total Cash (Recent Filing)€416.00K
Total Debt (Recent Filing)€128.29M
Price to Earnings (P/E)―
Beta0.30
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding22,741,629
10 Day Avg. Volume3,064
30 Day Avg. Volume4,678
Financial Highlights & Ratios
PEG Ratio-0.50
Price to Book (P/B)0.55
Price to Sales (P/S)0.31
P/FCF Ratio36.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Stable Operating MarginsConsistent EBITDA (≈20–25%) and EBIT (≈9–11%) margins indicate the core care-service operations generate recurring operating profitability. Over a multi-month horizon this supports resilience to demand swings, underpinning cash generation and the ability to fund operational needs without immediate structural change.
Consistent Operating Cash FlowRegular positive operating cash flow (roughly €5–10M annually) provides a durable internal funding source to cover working-capital needs and routine capex. This steady cash generation cushions the business against shortfalls in reported earnings and supports near-term liquidity and operational continuity.
Contract-based Revenue ModelRevenue tied to service fees and contractual arrangements with public and private payers creates a predictable, fee-for-service business model. Such contract-driven cash inflows reduce cyclicality of demand, aid planning, and foster long-term relationships with payers and institutions across the healthcare/social services ecosystem.
Bears Say
Very High LeverageA debt-to-equity ratio in the 3.3x–4.4x range with rising 2025 debt materially increases refinancing, covenant and interest-rate risk. Over the coming months high leverage constrains strategic flexibility, raises likelihood of higher funding costs, and makes the company sensitive to cash-flow volatility or adverse funding markets.
Recent Net LossesTransitioning from modest profits to net losses in 2024–2025 reduces retained earnings and erodes equity buffers. Persisting losses can impair access to capital, complicate refinancing or covenant compliance, and limit ability to invest in facilities or services unless operational improvements or funding actions restore profitability.
Volatile Free Cash FlowWide swings in free cash flow—deeply negative in 2024 and only marginally positive in 2025—signal inconsistent conversion of operating cash to surplus after capex and working-capital needs. This volatility complicates debt servicing plans, makes deleveraging unpredictable, and increases reliance on external financing in adverse months.
Eukedos S.p.A. News
EUK FAQ
What was Eukedos S.p.A.’s price range in the past 12 months?
Eukedos S.p.A. lowest stock price was €0.45 and its highest was €0.82 in the past 12 months.
What is Eukedos S.p.A.’s market cap?
Eukedos S.p.A.’s market cap is €14.90M.
When is Eukedos S.p.A.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Eukedos S.p.A.’s earnings last quarter?
Currently, no data Available
Is Eukedos S.p.A. overvalued?
According to Wall Street analysts Eukedos S.p.A.’s price is currently Overvalued.
Does Eukedos S.p.A. pay dividends?
Eukedos S.p.A. pays a Notavailable dividend of €0.044 which represents an annual dividend yield of N/A. See more information on Eukedos S.p.A. dividends here
What is Eukedos S.p.A.’s EPS estimate?
Eukedos S.p.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eukedos S.p.A. have?
Eukedos S.p.A. has 22,741,629 shares outstanding.
What happened to Eukedos S.p.A.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Eukedos S.p.A.?
Currently, no hedge funds are holding shares in IT:EUK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eukedos S.p.A.
EuKedos S.p.A. provides managed and long-term care services in Italy. The company offers residential social care services to elderly, self-sufficient, or incapacitated adults. It manages healthcare and assistance residences with 1,345 beds in the North and Central Italy, primarily located in Lombardy, Piedmont, Abruzzo, Valle D'Aosta, and Emilia Romagna. EuKedos S.p.A. is based in Florence, Italy.
Technical Analysis
Arterra Bioscience SpA
―
Farmacosmo S.P.A.
―
Farmae SpA
―
Laboratorio Farmaceutico Erfo SpA
―
Svas Biosana S.p.A.
―